Monitoring Chagas Disease Patients After Benznidazole Treatment
Author Information
Author(s): Fernández-Villegas Ana, Pinazo María Jesús, Marañón Concepción, Thomas M Carmen, Posada Elizabeth, Carrilero Bartolomé, Segovia Manuel, Gascon Joaquim, López Manuel C
Primary Institution: Instituto de Parasitología y Biomedicina López Neyra - Consejo Superior de Investigaciones Científicas (IPBLN-CSIC)
Hypothesis
Can immunological markers be used to monitor the effectiveness of benznidazole treatment in Chagas disease patients?
Conclusion
The study found that specific antigens can be used to monitor the effectiveness of benznidazole treatment in Chagas disease patients.
Supporting Evidence
- Sera from chagasic patients reacted significantly against KMP11, HSP70, PFR2, and Tgp63 compared to healthy donors.
- Post-treatment, a significant decrease in reactivity against KMP11, HSP70, and PFR2 was observed.
- The study included a diverse group of patients from different clinical stages of Chagas disease.
Takeaway
Doctors can check how well a medicine is working for Chagas disease by looking at certain proteins in the blood.
Methodology
The study analyzed serum reactivity against specific antigens in 46 Chagas disease patients before and after benznidazole treatment.
Limitations
The follow-up was limited to 35 patients due to some moving away, which may affect the results.
Participant Demographics
46 adult Chagas disease patients (15 indeterminate, 16 cardiomyopathy, 15 digestive) and 22 healthy controls.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website